Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities. Heterogeneity and drug resistance among tumors pose a serious challenge ...
Lead programme based on a first--in--class small--molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV--positive head and neck cancer -- Programme has demonstrated strong in ...
Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related protein called ezrin. This finding could potentially open ...
Researchers have developed a tiny antibody that can find a common cancer protein and make tumors light up during PET scans. In tests with mice, tumors containing the protein EphA2 glowed clearly when ...
In Michigan Tech's biology teaching lab, undergraduate students research potential cancer cures with help from the humble worm.
Tumor biology is increasingly recognized as a field shaped by the intricate interplay between malignant cells and their surrounding microenvironment. Recent ...
Salivary glands are essential for everyday human functions —speaking, swallowing, tasting and protecting the mouth—yet they ...
A newly discovered genetic switch may allow scientists to dramatically amplify the cancer-killing power of natural immune cells by harnessing the body’s own signaling molecules. Credit: Shutterstock ...
aThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA bPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA cIcahn Genomics ...
In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in ...
Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...